The Hague March 28, 2019
Disclaimers
Forward-looking statements
The statements contained in
this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target,
intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, could, is confident, will, and similar expressions as they relate to Aegon. These statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these
forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties.
Such risks and uncertainties include but are not limited to the following:
|
|
|
Changes in general economic and/or governmental conditions, particularly in the United States, the Netherlands
and the United Kingdom;
|
|
|
|
Changes in the performance of financial markets, including emerging markets, such as with regard to:
|
|
|
|
The frequency and severity of defaults by issuers in Aegons fixed income investment portfolios;
|
|
|
|
The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting
decline in the value of equity and debt securities Aegon holds; and
|
|
|
|
The effects of declining creditworthiness of certain public sector securities and the resulting decline in the
value of government exposure that Aegon holds;
|
|
|
|
Changes in the performance of Aegons investment portfolio and decline in ratings of Aegons
counterparties;
|
|
|
|
Consequences of an actual or potential
break-up
of the European monetary
union in whole or in part;
|
|
|
|
Consequences of the anticipated exit of the United Kingdom from the European Union and potential consequences of
other European Union countries leaving the European Union;
|
|
|
|
The frequency and severity of insured loss events;
|
|
|
|
Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the
profitability of Aegons insurance products;
|
|
|
|
Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations;
|
|
|
|
Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels;
|
|
|
|
Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates;
|
|
|
|
Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets
funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness;
|
|
|
|
Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets;
|
|
|
|
Changes in laws and regulations, particularly those affecting Aegons operations ability to hire and
retain key personnel, taxation of Aegon companies, the products Aegon sells, and the attractiveness of certain products to its consumers;
|
|
|
|
Regulatory changes relating to the pensions, investment, and insurance industries in the jurisdictions in which
Aegon operates;
|
|
|
|
Standard setting initiatives of supranational standard setting bodies such as the Financial Stability Board and
the International Association of Insurance Supervisors or changes to such standards that may have an impact on regional (such as EU), national or US federal or state level financial regulation or the application thereof to Aegon, including the
designation of Aegon by the Financial Stability Board as a Global Systemically Important Insurer
(G-SII);
|
|
|
|
Changes in customer behavior and public opinion in general related to, among other things, the type of products
Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations;
|
|
|
|
Acts of God, acts of terrorism, acts of war and pandemics;
|
|
|
|
Changes in the policies of central banks and/or governments;
|
|
|
|
Lowering of one or more of Aegons debt ratings issued by recognized rating organizations and the adverse
impact such action may have on Aegons ability to raise capital and on its liquidity and financial condition;
|
|
|
|
Lowering of one or more of insurer financial strength ratings of Aegons insurance subsidiaries and the
adverse impact such action may have on the premium writings, policy retention, profitability and liquidity of its insurance subsidiaries;
|
|
|
|
The effect of the European Unions Solvency II requirements and other regulations in other jurisdictions
affecting the capital Aegon is required to maintain;
|
|
|
|
Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does
business or both;
|
|
|
|
As Aegons operations support complex transactions and are highly dependent on the proper functioning of
information technology, operational risks such as system disruptions or failures, security or data privacy breaches, cyberattacks, human error, failure to safeguard personally identifiable information, changes in operational practices or inadequate
controls including with respect to third parties with which we do business may disrupt Aegons business, damage its reputation and adversely affect its results of operations, financial condition and cash flows;
|
|
|
|
Customer responsiveness to both new products and distribution channels;
|
|
|
|
Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for
Aegons products;
|
|
|
|
Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies,
voluntarily or otherwise, which may affect Aegons reported results, shareholders equity or regulatory capital adequacy levels;
|
|
|
|
Aegons projected results are highly sensitive to complex mathematical models of financial markets,
mortality, longevity, and other dynamic systems subject to shocks and unpredictable volatility. Should assumptions to these models later prove incorrect, or should errors in those models escape the controls in place to detect them, future
performance will vary from projected results;
|
|
|
|
The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items,
including Aegons ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions;
|
|
|
|
Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt
Aegons business; and
|
|
|
|
Aegons failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost
saving and excess cash and leverage ratio management initiatives.
|
This press release contains information that qualifies, or may
qualify, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation (596/2014). Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the
Financial Markets and the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly
disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegons expectations with regard thereto or any change in events, conditions or
circumstances on which any such statement is based
NOT FOR PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN VIOLATION OF THE
RELEVANT LAWS OF SUCH JURISDICTION.
The securities described herein have not been and will not be registered under the United States Securities Act of
1933, as amended (the US Securities Act) and are subject to certain United States tax law requirements. The securities may not be offered, sold or delivered in the United States absent registration or an applicable exemption from the
registration requirements under the US Securities Act. There will be no public offering of the securities in the United States.
2